DMD and neurofibromatosis type 1: In both neurogenetic disorders, the affected proteins (i.e. dystrophin in DMD and neurofibromin in NF1) are expressed in a wide variety of nervous tissues including neurons and glial cells (e.g. astrocytes, oligodendrocytes) in the brain [7, 10, 30, 80–82].